GlassScriptPhysician profile
Jill B Cole
NPI 1467424531
$5,090.64
in general payments reported to CMS, 2019-2025
39 companies · $583 in 2025
The $583 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $397 · 2021: $927 · 2022: $921 · 2023: $903 · 2024: $791 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,239 · Education: $37.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,239.39 |
| Education | $37.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $647.99 | 2020-2025 | Darzalex, Tecvayli, Talvey |
| Seagen INC. | $458.72 | 2019-2023 | Padcev |
| E.R. Squibb & Sons, L.L.C. | $440.70 | 2019-2025 | Opdivo, Opdualag |
| Astellas Pharma US INC | $380.73 | 2019-2025 | Padcev, Xtandi, Xospata |
| Glaxosmithkline, LLC. | $325.14 | 2021-2025 | Zejula, Ojjaara |
| Coherus Oncology, INC. | $278.39 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $272.07 | 2020-2025 | Piqray, Kisqali |
| Pfizer INC. | $240.23 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $232.84 | 2021-2025 | Calquence |
| Pharmacyclics LLC, An Abbvie Company | $184.61 | 2021-2023 | Imbruvica |
| Amgen INC. | $141.02 | 2019-2022 | |
| Eisai INC. | $129.95 | 2019-2020 | |
| Genentech USA, INC. | $124.33 | 2019-2022 | |
| Sirtex Medical INC | $111.34 | 2022 | |
| Acrotech Biopharma INC. | $97.82 | 2023-2024 | Beleodaq |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.